干眼症模型（2023）

新资讯

本报告分析了全球干眼市场，并提供了人口在 100 万或以上的国家中 13 种干眼相关项目的患病率数据（按年龄组和国家）以及 5 年数据。

目录

本报告提供了人口超过 100 万的国家（总共 228 个国家）按国家和年龄组划分的以下疾病的盛行率数据：

• 临床前干眼症
• 干眼症
• 有干眼风险的人
• 类风湿性关节炎伴随干眼症
• 系统性关节炎伴随干眼症
• 狼疮伴随干眼症
• 全身性疾病（不包括伴随干眼的干燥症）
• 眼睛过敏伴随干眼症
• 睑板腺功能障碍合併干眼症
• 伴随干眼症的干燥症
• 患有干眼症的隐形眼镜配戴者
• 与干眼症相关的全身性药物

What's New:

Market Scope's "2023 Dry Eye Disease Model" offers extensive country-level prevalence data and five-year forecasts for 13 dry eye-related segments of the population by age group for all countries with a population over a million.

This proprietary model takes into consideration the latest clinical research and demographic projections on a global scale and can be customized by geography and disease category to meet clients' diverse needs. Disease models can be used to evaluate target markets for clinical-stage and commercial-stage products and gain insights into the volume and demographics of diseased populations.

Contents:

The "2023 Dry Eye Disease Model" provides country-level prevalence data by age group for the 228 countries with a population over a million for the following conditions:

• Preclinical dry eye
• Dry eye
• Those at risk for dry eye
• Rheumatoid arthritis with dry eye
• Systemic arthritis with dry eye
• Lupus with dry eye
• Systemic diseases (not including Sjogren's population with dry eye)
• Ocular allergies with dry eye
• Meibomian gland dysfunction with dry eye
• Sjogren's with dry eye
• Contact lens wearer with dry eye
• Systemic drugs with dry eye